Global Spinal Muscular Atrophy Market Insights and Forecast to 2028

Publisher Name :
Date: 25-Mar-2022
No. of pages: 92
Inquire Before Buying

Spinal Muscular Atrophy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Spinal Muscular Atrophy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Early Stage Candidates

- Late Stage Candidates

Segment by Application

- Hospital

- Clinic

- Others

By Company

- Lonis Pharmaceuticals

- F. Hoffmann-La Roche

- AveXis

- Novartis

- Cytokinetics

- Ionis Pharmaceuticals

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Spinal Muscular Atrophy Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Early Stage Candidates
1.2.3 Late Stage Candidates
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy Market Perspective (2017-2028)
2.2 Spinal Muscular Atrophy Growth Trends by Region
2.2.1 Spinal Muscular Atrophy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Spinal Muscular Atrophy Historic Market Size by Region (2017-2022)
2.2.3 Spinal Muscular Atrophy Forecasted Market Size by Region (2023-2028)
2.3 Spinal Muscular Atrophy Market Dynamics
2.3.1 Spinal Muscular Atrophy Industry Trends
2.3.2 Spinal Muscular Atrophy Market Drivers
2.3.3 Spinal Muscular Atrophy Market Challenges
2.3.4 Spinal Muscular Atrophy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy Players by Revenue (2017-2022)
3.1.2 Global Spinal Muscular Atrophy Revenue Market Share by Players (2017-2022)
3.2 Global Spinal Muscular Atrophy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Spinal Muscular Atrophy Revenue
3.4 Global Spinal Muscular Atrophy Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Revenue in 2021
3.5 Spinal Muscular Atrophy Key Players Head office and Area Served
3.6 Key Players Spinal Muscular Atrophy Product Solution and Service
3.7 Date of Enter into Spinal Muscular Atrophy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Muscular Atrophy Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy Historic Market Size by Type (2017-2022)
4.2 Global Spinal Muscular Atrophy Forecasted Market Size by Type (2023-2028)
5 Spinal Muscular Atrophy Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy Historic Market Size by Application (2017-2022)
5.2 Global Spinal Muscular Atrophy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Spinal Muscular Atrophy Market Size (2017-2028)
6.2 North America Spinal Muscular Atrophy Market Size by Type
6.2.1 North America Spinal Muscular Atrophy Market Size by Type (2017-2022)
6.2.2 North America Spinal Muscular Atrophy Market Size by Type (2023-2028)
6.2.3 North America Spinal Muscular Atrophy Market Share by Type (2017-2028)
6.3 North America Spinal Muscular Atrophy Market Size by Application
6.3.1 North America Spinal Muscular Atrophy Market Size by Application (2017-2022)
6.3.2 North America Spinal Muscular Atrophy Market Size by Application (2023-2028)
6.3.3 North America Spinal Muscular Atrophy Market Share by Application (2017-2028)
6.4 North America Spinal Muscular Atrophy Market Size by Country
6.4.1 North America Spinal Muscular Atrophy Market Size by Country (2017-2022)
6.4.2 North America Spinal Muscular Atrophy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Spinal Muscular Atrophy Market Size (2017-2028)
7.2 Europe Spinal Muscular Atrophy Market Size by Type
7.2.1 Europe Spinal Muscular Atrophy Market Size by Type (2017-2022)
7.2.2 Europe Spinal Muscular Atrophy Market Size by Type (2023-2028)
7.2.3 Europe Spinal Muscular Atrophy Market Share by Type (2017-2028)
7.3 Europe Spinal Muscular Atrophy Market Size by Application
7.3.1 Europe Spinal Muscular Atrophy Market Size by Application (2017-2022)
7.3.2 Europe Spinal Muscular Atrophy Market Size by Application (2023-2028)
7.3.3 Europe Spinal Muscular Atrophy Market Share by Application (2017-2028)
7.4 Europe Spinal Muscular Atrophy Market Size by Country
7.4.1 Europe Spinal Muscular Atrophy Market Size by Country (2017-2022)
7.4.2 Europe Spinal Muscular Atrophy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy Market Size (2017-2028)
8.2 Asia-Pacific Spinal Muscular Atrophy Market Size by Type
8.2.1 Asia-Pacific Spinal Muscular Atrophy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Spinal Muscular Atrophy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Spinal Muscular Atrophy Market Share by Type (2017-2028)
8.3 Asia-Pacific Spinal Muscular Atrophy Market Size by Application
8.3.1 Asia-Pacific Spinal Muscular Atrophy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Spinal Muscular Atrophy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Spinal Muscular Atrophy Market Share by Application (2017-2028)
8.4 Asia-Pacific Spinal Muscular Atrophy Market Size by Region
8.4.1 Asia-Pacific Spinal Muscular Atrophy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Spinal Muscular Atrophy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Spinal Muscular Atrophy Market Size (2017-2028)
9.2 Latin America Spinal Muscular Atrophy Market Size by Type
9.2.1 Latin America Spinal Muscular Atrophy Market Size by Type (2017-2022)
9.2.2 Latin America Spinal Muscular Atrophy Market Size by Type (2023-2028)
9.2.3 Latin America Spinal Muscular Atrophy Market Share by Type (2017-2028)
9.3 Latin America Spinal Muscular Atrophy Market Size by Application
9.3.1 Latin America Spinal Muscular Atrophy Market Size by Application (2017-2022)
9.3.2 Latin America Spinal Muscular Atrophy Market Size by Application (2023-2028)
9.3.3 Latin America Spinal Muscular Atrophy Market Share by Application (2017-2028)
9.4 Latin America Spinal Muscular Atrophy Market Size by Country
9.4.1 Latin America Spinal Muscular Atrophy Market Size by Country (2017-2022)
9.4.2 Latin America Spinal Muscular Atrophy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy Market Size (2017-2028)
10.2 Middle East & Africa Spinal Muscular Atrophy Market Size by Type
10.2.1 Middle East & Africa Spinal Muscular Atrophy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Spinal Muscular Atrophy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Spinal Muscular Atrophy Market Share by Type (2017-2028)
10.3 Middle East & Africa Spinal Muscular Atrophy Market Size by Application
10.3.1 Middle East & Africa Spinal Muscular Atrophy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Spinal Muscular Atrophy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Spinal Muscular Atrophy Market Share by Application (2017-2028)
10.4 Middle East & Africa Spinal Muscular Atrophy Market Size by Country
10.4.1 Middle East & Africa Spinal Muscular Atrophy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Spinal Muscular Atrophy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonis Pharmaceuticals
11.1.1 Lonis Pharmaceuticals Company Details
11.1.2 Lonis Pharmaceuticals Business Overview
11.1.3 Lonis Pharmaceuticals Spinal Muscular Atrophy Introduction
11.1.4 Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2017-2022)
11.1.5 Lonis Pharmaceuticals Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Spinal Muscular Atrophy Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 AveXis
11.3.1 AveXis Company Details
11.3.2 AveXis Business Overview
11.3.3 AveXis Spinal Muscular Atrophy Introduction
11.3.4 AveXis Revenue in Spinal Muscular Atrophy Business (2017-2022)
11.3.5 AveXis Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Spinal Muscular Atrophy Introduction
11.4.4 Novartis Revenue in Spinal Muscular Atrophy Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Cytokinetics
11.5.1 Cytokinetics Company Details
11.5.2 Cytokinetics Business Overview
11.5.3 Cytokinetics Spinal Muscular Atrophy Introduction
11.5.4 Cytokinetics Revenue in Spinal Muscular Atrophy Business (2017-2022)
11.5.5 Cytokinetics Recent Developments
11.6 Ionis Pharmaceuticals
11.6.1 Ionis Pharmaceuticals Company Details
11.6.2 Ionis Pharmaceuticals Business Overview
11.6.3 Ionis Pharmaceuticals Spinal Muscular Atrophy Introduction
11.6.4 Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2017-2022)
11.6.5 Ionis Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Spinal Muscular Atrophy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Early Stage Candidates
Table 3. Key Players of Late Stage Candidates
Table 4. Global Spinal Muscular Atrophy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Spinal Muscular Atrophy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Spinal Muscular Atrophy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Spinal Muscular Atrophy Market Share by Region (2017-2022)
Table 8. Global Spinal Muscular Atrophy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Spinal Muscular Atrophy Market Share by Region (2023-2028)
Table 10. Spinal Muscular Atrophy Market Trends
Table 11. Spinal Muscular Atrophy Market Drivers
Table 12. Spinal Muscular Atrophy Market Challenges
Table 13. Spinal Muscular Atrophy Market Restraints
Table 14. Global Spinal Muscular Atrophy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Spinal Muscular Atrophy Revenue Share by Players (2017-2022)
Table 16. Global Top Spinal Muscular Atrophy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy as of 2021)
Table 17. Ranking of Global Top Spinal Muscular Atrophy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Spinal Muscular Atrophy Product Solution and Service
Table 21. Date of Enter into Spinal Muscular Atrophy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Spinal Muscular Atrophy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Spinal Muscular Atrophy Revenue Market Share by Type (2017-2022)
Table 25. Global Spinal Muscular Atrophy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Spinal Muscular Atrophy Revenue Market Share by Type (2023-2028)
Table 27. Global Spinal Muscular Atrophy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Spinal Muscular Atrophy Revenue Share by Application (2017-2022)
Table 29. Global Spinal Muscular Atrophy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Spinal Muscular Atrophy Revenue Share by Application (2023-2028)
Table 31. North America Spinal Muscular Atrophy Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Spinal Muscular Atrophy Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Spinal Muscular Atrophy Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Spinal Muscular Atrophy Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Spinal Muscular Atrophy Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Spinal Muscular Atrophy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Spinal Muscular Atrophy Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Spinal Muscular Atrophy Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Spinal Muscular Atrophy Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Spinal Muscular Atrophy Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Spinal Muscular Atrophy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Spinal Muscular Atrophy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Spinal Muscular Atrophy Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Spinal Muscular Atrophy Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Spinal Muscular Atrophy Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Spinal Muscular Atrophy Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Spinal Muscular Atrophy Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Spinal Muscular Atrophy Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Spinal Muscular Atrophy Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Spinal Muscular Atrophy Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Spinal Muscular Atrophy Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Spinal Muscular Atrophy Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Spinal Muscular Atrophy Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Spinal Muscular Atrophy Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Spinal Muscular Atrophy Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Spinal Muscular Atrophy Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Spinal Muscular Atrophy Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Spinal Muscular Atrophy Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Spinal Muscular Atrophy Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Spinal Muscular Atrophy Market Size by Country (2023-2028) & (US$ Million)
Table 61. Lonis Pharmaceuticals Company Details
Table 62. Lonis Pharmaceuticals Business Overview
Table 63. Lonis Pharmaceuticals Spinal Muscular Atrophy Product
Table 64. Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2017-2022) & (US$ Million)
Table 65. Lonis Pharmaceuticals Recent Developments
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Spinal Muscular Atrophy Product
Table 69. F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2017-2022) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Developments
Table 71. AveXis Company Details
Table 72. AveXis Business Overview
Table 73. AveXis Spinal Muscular Atrophy Product
Table 74. AveXis Revenue in Spinal Muscular Atrophy Business (2017-2022) & (US$ Million)
Table 75. AveXis Recent Developments
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Spinal Muscular Atrophy Product
Table 79. Novartis Revenue in Spinal Muscular Atrophy Business (2017-2022) & (US$ Million)
Table 80. Novartis Recent Developments
Table 81. Cytokinetics Company Details
Table 82. Cytokinetics Business Overview
Table 83. Cytokinetics Spinal Muscular Atrophy Product
Table 84. Cytokinetics Revenue in Spinal Muscular Atrophy Business (2017-2022) & (US$ Million)
Table 85. Cytokinetics Recent Developments
Table 86. Ionis Pharmaceuticals Company Details
Table 87. Ionis Pharmaceuticals Business Overview
Table 88. Ionis Pharmaceuticals Spinal Muscular Atrophy Product
Table 89. Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2017-2022) & (US$ Million)
Table 90. Ionis Pharmaceuticals Recent Developments
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal Muscular Atrophy Market Share by Type: 2021 VS 2028
Figure 2. Early Stage Candidates Features
Figure 3. Late Stage Candidates Features
Figure 4. Global Spinal Muscular Atrophy Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Spinal Muscular Atrophy Report Years Considered
Figure 9. Global Spinal Muscular Atrophy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Spinal Muscular Atrophy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Spinal Muscular Atrophy Market Share by Region: 2021 VS 2028
Figure 12. Global Spinal Muscular Atrophy Market Share by Players in 2021
Figure 13. Global Top Spinal Muscular Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Revenue in 2021
Figure 15. North America Spinal Muscular Atrophy Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Spinal Muscular Atrophy Market Size Market Share by Type (2017-2028)
Figure 17. North America Spinal Muscular Atrophy Market Size Market Share by Application (2017-2028)
Figure 18. North America Spinal Muscular Atrophy Market Size Share by Country (2017-2028)
Figure 19. United States Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Spinal Muscular Atrophy Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Spinal Muscular Atrophy Market Size Market Share by Type (2017-2028)
Figure 23. Europe Spinal Muscular Atrophy Market Size Market Share by Application (2017-2028)
Figure 24. Europe Spinal Muscular Atrophy Market Size Share by Country (2017-2028)
Figure 25. Germany Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Spinal Muscular Atrophy Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Spinal Muscular Atrophy Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Spinal Muscular Atrophy Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Spinal Muscular Atrophy Market Size Share by Region (2017-2028)
Figure 35. China Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Spinal Muscular Atrophy Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Spinal Muscular Atrophy Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Spinal Muscular Atrophy Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Spinal Muscular Atrophy Market Size Share by Country (2017-2028)
Figure 45. Mexico Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Spinal Muscular Atrophy Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Spinal Muscular Atrophy Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Spinal Muscular Atrophy Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Spinal Muscular Atrophy Market Size Share by Country (2017-2028)
Figure 51. Turkey Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Spinal Muscular Atrophy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Lonis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2017-2022)
Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy Business (2017-2022)
Figure 56. AveXis Revenue Growth Rate in Spinal Muscular Atrophy Business (2017-2022)
Figure 57. Novartis Revenue Growth Rate in Spinal Muscular Atrophy Business (2017-2022)
Figure 58. Cytokinetics Revenue Growth Rate in Spinal Muscular Atrophy Business (2017-2022)
Figure 59. Ionis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
  • Global Gynecology Partnering 2010-2023: Deal trends, players and financials
    Published: 01-Jun-2023        Price: US 3995 Onwards        Pages: 300
    The Global Gynecology Partnering 2010-2023: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the gynecology partnering deals and agreements entered into by the worlds leading healthcare companies......
  • Global Imbruvica Market Insights, Forecast to 2029
    Published: 30-May-2023        Price: US 4900 Onwards        Pages: 74
    Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia. Market Analysis and Insights: Global Imbruvica Market The global Imbruvica market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast ......
  • Global Emergency Medical Services (EMS) Market Insights, Forecast to 2029
    Published: 30-May-2023        Price: US 4900 Onwards        Pages: 127
    Emergency Medical Services (EMS) is a kind of sudden Emergency time for quick Medical assistance Services. Market Analysis and Insights: Global Emergency Medical Services (EMS) Market The global Emergency Medical Services (EMS) market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Factors driving the growth of this market include high demand for emergency care, increasing incidenc......
  • Global Electroceuticals & Bioelectric Market Insights, Forecast to 2029
    Published: 30-May-2023        Price: US 4900 Onwards        Pages: 110
    Electroceuticals/Bioelectric encompass medical devices that use electrical impulses to modulate the body's neural circuits as an alternative to drug-based intervention. Market Analysis and Insights: Global Electroceuticals & Bioelectric Market The global Electroceuticals & Bioelectric market is projected to grow from US$ 18880 million in 2023 to US$ 29800 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.9% during the forecast period. The market growth can be att......
  • Global ECG Equipment & Management System Market Insights, Forecast to 2029
    Published: 30-May-2023        Price: US 4900 Onwards        Pages: 106
    ECG Equipment & Management System as a routine examination items of heart disease, is widely used in the medical units at all levels, to produce a day to rest ecg of a large number of ecg data. Market Analysis and Insights: Global ECG Equipment & Management System Market The global ECG Equipment & Management System market is projected to grow from US$ 5162 million in 2023 to US$ 7239.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.......
  • Global Durable Medical Equipment (DME) Market Insights, Forecast to 2029
    Published: 30-May-2023        Price: US 4900 Onwards        Pages: 97
    Durable Medical Equipment (DME) is a medical equipment that durable, can be used in the home and have at least 3 years of life expectancy. The global Durable Medical Equipment (DME) market is projected to grow from US$ 190640 million in 2023 to US$ 282900 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period. The prevalence of chronic conditions, such as heart disorders, cancer, gynecological disorders, and neurological disorder is on a rise, d......
  • Global Drug of Abuse Testing Services Market Insights, Forecast to 2029
    Published: 30-May-2023        Price: US 4900 Onwards        Pages: 95
    Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. Market Analysis and Insights: Global Drug of Abuse Testing Services Market The global Drug of Abuse Testing Services market is projected to grow from US$ 1729.5 million in 2023 to US$ 2714.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period. In addition to rise in number of substance abusers and increase......
  • Global Drug And Gene Delivery Devices Market Insights, Forecast to 2029
    Published: 30-May-2023        Price: US 4900 Onwards        Pages: 113
    Drug And Gene Delivery Devices provides a new treatment method, become the main treatment of the global market. The global Drug And Gene Delivery Devices market is projected to grow from US$ 158310 million in 2023 to US$ 627450 million by 2029, at a Compound Annual Growth Rate (CAGR) of 25.8% during the forecast period. The global market is being driven by the introduction of auto-injectors, adoption of advanced implants, and development of advanced devices that have revolutionized......
  • Global DNA Testing & Diagnostics Market Insights, Forecast to 2029
    Published: 30-May-2023        Price: US 4900 Onwards        Pages: 112
    DNA Testing/Diagnostics is the determination of bloodlinesand the genetic diagnosis of vulnerabilities to inherited diseases. Market Analysis and Insights: Global DNA Testing & Diagnostics Market The global DNA Testing & Diagnostics market is projected to grow from US$ 12520 million in 2023 to US$ 24190 million by 2029, at a Compound Annual Growth Rate (CAGR) of 11.6% during the forecast period. With the rising incidences of genetic, infectious, and chronic diseases, reducti......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs